• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大剂量静脉注射丙种球蛋白治疗川崎病

[Treatment of Kawasaki's syndrome with high dose intravenous gammaglobulins].

作者信息

Teulon G, Pierron H, Horte C, Orsini A

出版信息

Pediatrie. 1986 Jan-Feb;41(1):65-9.

PMID:2425335
Abstract

The apparition of coronary aneurysms in Kawasaki syndrome is the reason for the serious nature of this disease. Many attempts have been made to prevent this complication. Two children, respectively 10 and 28 months old, were treated in our unit with salicylate and high dose intravenous gammaglobulin by analogy with the treatment of idiopathic thrombocytopenic purpura. The clinical, electrical, radiological, echographic cardiac surveillance did not show any sign of aneurysms more than 6 months after the onset of the disease. Following the Furusho's study, high dose intravenous gammaglobulin seems to reduce the frequency of coronary aneurysms in patients with Kawasaki syndrome.

摘要

川崎病中冠状动脉瘤的出现是该疾病严重性的原因。人们已经进行了许多尝试来预防这种并发症。我们科室对两名分别为10个月和28个月大的儿童,采用了与特发性血小板减少性紫癜治疗类似的方法,给予水杨酸盐和大剂量静脉注射丙种球蛋白进行治疗。在疾病发作6个多月后,临床、心电图、放射学、超声心动图心脏监测均未显示出任何动脉瘤的迹象。根据古吕庄的研究,大剂量静脉注射丙种球蛋白似乎可以降低川崎病患者冠状动脉瘤的发生率。

相似文献

1
[Treatment of Kawasaki's syndrome with high dose intravenous gammaglobulins].大剂量静脉注射丙种球蛋白治疗川崎病
Pediatrie. 1986 Jan-Feb;41(1):65-9.
2
[Trial of prevention of coronary aneurysm in Kawasaki's disease using plasma exchange or infusion of immunoglobulins].[使用血浆置换或输注免疫球蛋白预防川崎病冠状动脉瘤的试验]
Arch Fr Pediatr. 1987 Feb;44(2):79-83.
3
[Kawasaki's syndrome. Major therapeutic advances provided by gammaglobulins].[川崎病。丙种球蛋白带来的主要治疗进展]
Rev Prat. 1992 Sep 15;42(14):1779-82.
4
Management and outcome of intravenous gammaglobulin-resistant Kawasaki disease.静脉注射免疫球蛋白抵抗性川崎病的管理与结局
Singapore Med J. 2006 Sep;47(9):780-4.
5
[Effects of three intravenous gamma globulin regimens on Kawasaki disease and relevant coronary complication rates in pediatric patients: a comparative study].[三种静脉注射丙种球蛋白方案对小儿川崎病及相关冠状动脉并发症发生率的影响:一项对比研究]
Zhonghua Yi Xue Za Zhi. 2007 Nov 27;87(44):3119-21.
6
[Kawasaki disease--personal observations].[川崎病——个人观察]
Wiad Lek. 2001;54(3-4):215-8.
7
[Intravenous gammaglobulins and prevention of cardiovascular risk in Kawasaki's disease. Reflections apropos of a case].[静脉注射丙种球蛋白与川崎病心血管风险的预防。关于一例病例的思考]
Arch Fr Pediatr. 1984 Jun-Jul;41(6):441.
8
[Risk factors in Kawasaki's syndrome].[川崎病的危险因素]
Tidsskr Nor Laegeforen. 2004 Jul 1;124(13-14):1764-6.
9
[Kawasaki disease. Treatment with intravenous gammaglobulins].[川崎病。静脉注射丙种球蛋白治疗]
Presse Med. 1989 Jun 10;18(23):1147-50.
10
[A case of Kawasaki's syndrome in an adult. Value of treatment with intravenous gammaglobulins].[一例成人川崎病。静脉注射丙种球蛋白治疗的价值]
Presse Med. 1986 Apr 19;15(16):760.